Internet Archive Scholar

Additional file 8: Figure S7. of Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells [stub]

Amani Moraya, Jennifer Ali, Pranati Samadder, Lisa Liang, Ludivine Morrison, Tamra Werbowetski-Ogilvie, Makanjuola Ogunsina, Frank Schweizer, Gilbert Arthur, Mark Nachtigal
2017 Figshare  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (856.1 kB)
https://web.archive.org/web/20200112161620/https://s3-eu-west-1.amazonaws.com/pstorage-npg-968563215/8431091/13046_2017_538_MOESM8_ESM.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

Viability of primary EOC183A cells treated with GAELs alone or pretreated with the pan-caspase inhibitor QVD. No significant difference in cell viability was observed in the presence of QVD, with the exception of the cisplatin positive control. * significantly different from vehicle control; + significantly different from cisplatin alone; pâ
doi:10.6084/m9.figshare.c.3778562_d8.v1 fatcat:tahshe3plrc6db3mjki7bmuvrq
Open Access
Citation

Amani Moraya, Jennifer Ali, Pranati Samadder, Lisa Liang, Ludivine Morrison, Tamra Werbowetski-Ogilvie, Makanjuola Ogunsina, Frank Schweizer, Gilbert Arthur, Mark Nachtigal. "Additional file 8: Figure S7. of Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells." Figshare (2017)